Rosenfield Stephen

Avg. Two Year Performance

40% Avg. Purchase Return
18% Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(< 1%)2%(17%)9%40%
Purchase Success Rate1 of 21 of 21 of 21 of 22 of 2
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Geron Corp

Drugs » Drug Manufacturers - Other

EVP, Chief Legal Off & Sec:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

InterMune Inc.

Drugs » Biotechnology

Exec. Vice President of:

Holdings: 61.12K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Tercica Inc.

Other » Other

Executive VP of Legal Affairs:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--